Accelerating Vaccine Development through Use of Blood-Free Components

This GEN webinar, sponsored by Invitria, will discuss the real contamination risks described in a recent study and how companies are rising to this challenge through a better selection of components and excipients.

The post Accelerating Vaccine Development through Use of Blood-Free Components appeared first on GEN – Genetic Engineering and Biotechnology News.

Published on Fri, 08 Jan 2021 22:28:13 +0000 and sponsored by nintex duration